Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Maravai LifeSciences Holdings, Inc. - Class A common stock (NQ:MRVI)

2.400 -0.030 (-1.23%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 20, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Maravai LifeSciences Holdings, Inc. - Class A common stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
This Analyst With 85% Accuracy Rate Sees Over 29% Upside In NVIDIA - Here Are 5 Stock Picks For Last Week From Wall Street's Most Accurate Analysts
US stocks closed lower on Friday, with the Dow Jones dropping more than 300 points during the session. 
Via Benzinga
The Latest Analyst Ratings for Maravai LifeSciences
Via Benzinga
Comfort Systems, Gannett, CommScope And Other Big Stocks Moving Higher On Thursday
U.S. stocks traded slightly lower, with the Dow Jones dropping around 30 points on Thursday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Earnings Outlook For Maravai LifeSciences
Via Benzinga
5 Value Stocks In The Healthcare Sector
Via Benzinga
Where Maravai LifeSciences Stands With Analysts
Via Benzinga
6 Analysts Have This to Say About Maravai LifeSciences
Via Benzinga
Why Domino's Pizza Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers 
Via Benzinga
Maravai LifeSciences (MRVI) Q4 2022 Earnings Call Transcript
MRVI earnings call for the period ending December 31, 2022. 
Via The Motley Fool
Maravai LifeSciences Reports Fourth Quarter and Full Year 2022 Financial Results
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
Where Maravai LifeSciences Stands With Analysts
Analysts have provided the following ratings for Maravai LifeSciences (NASDAQ:MRVI) within the last quarter: 
Via Benzinga
Analyst Ratings for Maravai LifeSciences
Analysts have provided the following ratings for Maravai LifeSciences (NASDAQ:MRVI) within the last quarter: 
Via Benzinga
Earnings Scheduled For February 22, 2023
Companies Reporting Before The Bell • Rio Tinto (NYSE:RIO) is projected to report earnings for its Fiscal Year 2022. 
Via Benzinga
2 Healthcare Companies That Could Be Acquired Within 5 Years
These stocks are also cheap buys that are down more than 60% from their highs. 
Via The Motley Fool
Catalent Hits Four-Month High As Danaher Reportedly Mulls A Takeover
Danaher is reportedly looking to add to its wheelhouse to compete with Thermo. 
Via Investor's Business Daily
Maravai LifeSciences to Host Earnings Conference Call on Wednesday, February 22, 2023
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
3 Great Growth Stocks Down 20% or More to Buy Now
These beaten-down stocks could be poised for major rebounds. 
Via The Motley Fool
3 Biopharma Stocks That Could Help Make You a Fortune
All three are protected by sales of in-demand products, with more on the way. 
Via The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2023
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 14, 2022
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
  During Thursday's trading, 138 companies set new 52-week lows. 
Via Benzinga
Maravai LifeSciences Announces Updated CEO Leadership Transition Plans
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
2 Biotech Stocks You Can Buy and Hold for the Next Decade
These two companies are facing short-term issues that are likely to give way to long-term success. 
Via The Motley Fool
Maravai LifeSciences Named to the 2022 Deloitte Technology Fast 500™ List of Fastest-Growing Companies in North America
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
New Kit Predicts Retroviral Particle Clearance in Biopharmaceutical Manufacturing
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
What 6 Analyst Ratings Have To Say About Maravai LifeSciences
Within the last quarter, Maravai LifeSciences (NASDAQ:MRVI) has observed the following analyst ratings: 
Via Benzinga
Maravai LifeSciences Announces November and December 2022 Investor Conference Schedule
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
We're starting off the day with a look at the latest news behind the biggest pre-market stock movers for Thursday morning! 
Via InvestorPlace
Maravai LifeSciences Holdings, Inc. (MRVI) Q3 2022 Earnings Call Transcript
MRVI earnings call for the period ending September 30, 2022. 
Via The Motley Fool
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.